hit counter
ADMA Biologics, Inc. (ADMA) Stock News Sentiment & Price - Sentifly
ADMA - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



ADMA Biologics, Inc. (ADMA)

USA
Biotechnology
NASDAQ
ADMA Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
ADMA Latest news
Benzinga
Neutral
ADMA Biologics Shares Rise On Lower Than Expected Q3 Loss, Sales Double
2021-11-11 07:49

ADMA Biologics Inc (NASDAQ: ADMA) achieved Q3 sales of $20.7 million, + 101% Y/Y, beating the consensus of $18.72 million. The increase was favorably impacted by the continued commercial ramp-up of ADMA's intravenous immune globulin (IVIG) product portfolio and the sale of intermediate fractions.

Seeking Alpha
Neutral
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call Transcript
2021-11-10 20:41

ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call Transcript

Zacks Investment Research
Positive
Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates
2021-11-10 19:05

Adma Biologics (ADMA) delivered earnings and revenue surprises of 13.33% and 11.29%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire
Neutral
ADMA Biologics Reports Record Third Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments
2021-11-10 16:01

Generated Record Total Revenues of $20.7 Million in the Third Quarter 2021, a 101% Increase Over Third Quarter 2020

Benzinga
Neutral
Preview: ADMA Biologics's Earnings
2021-11-09 10:58

ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2021-11-10. Here's what investors need to know before the announcement.

GlobeNewsWire
Neutral
ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021
2021-11-03 07:00

Conference Call Scheduled for November 10, 2021 at 4:30 p.m. ET Conference Call Scheduled for November 10, 2021 at 4:30 p.m. ET

Seeking Alpha
Neutral
ADMA: Insiders Showing Their Cards
2021-11-02 18:02

ADMA has been trading in a downward trajectory over the past few years. ADMA's stock price has taken a beating from several equity offerings as the business continues to invest in the future.

Zacks Investment Research
Negative
Will Adma Biologics (ADMA) Report Negative Q3 Earnings? What You Should Know
2021-10-28 16:48

Adma Biologics (ADMA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire
Neutral
ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
2021-10-25 16:01

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 25, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the closing of its previously announced underwritten public offering of 50 million shares of its common stock at a public offering price of $1.00 per share, in addition to the exercise in full of the underwriters' option to purchase an additional 7.5 million shares of common stock. The gross proceeds from the exercise of the overallotment option were $7.5 million, bringing the total gross proceeds to ADMA from the offering to $57.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses.

PennyStocks
Positive
Best Penny Stocks to Watch as The Market Turns Bullish
2021-10-22 09:28

Penny stocks are seeing heightened momentum, which companies are you watching? The post Best Penny Stocks to Watch as The Market Turns Bullish appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Loading more news...